Market research
TTB.AU Total Brain Limited
AU AUD Healthcare
Latest close
Latest stored close unavailable
Test a moving-average rule with historical data.
Market facts
- Market cap
- 267K
- P/E ratio
- Not available
- Analyst target
- 0.24
- Dividend yield
- 0.0%
- Beta
- 1.37
Profile
Instrument facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Health Information Services
- ISIN
- AU0000032435
- Market cap
- 267K
- P/E ratio
- Not available
- Analyst target
- 0.24
- Dividend yield
- 0.0%
- Beta
- 1.37
About
About Total Brain Limited
Total Brain Limited operates as an applied integrative neuroscience company in the United States and Australia. The company offers Total Brain, a mental health monitoring and support platform, that helps users to measure their brain capacities while managing the risk of common mental conditions. It serves companies, providers, affinity groups, and precision medicine sectors. The company was formerly known as Brain Resource Limited and changed its name to Total Brain Limited in December 2018. Total Brain Limited was incorporated in 2000 and is based in Surry Hills, Australia.
Research context
Total Brain Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Health Information Services
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the TTB.AU discussion.
5 years, 6 months ago
Total Brain Limited is currently in a long term downtrend where the price is trading 2.4% below its 200 day moving average.
From a valuation standpoint, the stock is 95.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 10.6.
Total Brain Limited's total revenue sank by 9.1% to $2M since the same quarter in the previous year.
Its net income has dropped by 3.5% to $-4M since the same quarter in the previous year.
Finally, its free cash flow grew by 33.6% to $-2M since the same quarter in the previous year.
Based on the above factors, Total Brain Limited gets an overall score of 2/5.